OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?
Rex Devasahayam Arokia Balaya, Sumaithangi Thattai Arun Kumar, Prashant Kumar Modi, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 7, pp. 408-416
Closed Access | Times Cited: 8
Rex Devasahayam Arokia Balaya, Sumaithangi Thattai Arun Kumar, Prashant Kumar Modi, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 7, pp. 408-416
Closed Access | Times Cited: 8
Showing 8 citing articles:
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 61
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 61
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases
Rex Devasahayam Arokia Balaya, Neelanchal Vaid, K Deepak, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9915-9927
Open Access | Times Cited: 23
Rex Devasahayam Arokia Balaya, Neelanchal Vaid, K Deepak, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9915-9927
Open Access | Times Cited: 23
Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls
Jintao Xu, Bing He, Kyle A. Carver, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Jintao Xu, Bing He, Kyle A. Carver, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation
Shikha Thakur, Apurba Sinhari, Anil Bhanudas Gaikwad, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 756, pp. 110019-110019
Closed Access | Times Cited: 3
Shikha Thakur, Apurba Sinhari, Anil Bhanudas Gaikwad, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 756, pp. 110019-110019
Closed Access | Times Cited: 3
Роль брадикініну в розвитку COVID-19 та інших захворювань
V.M. Pushkarev, О.І. Ковзун, Н.І. Левчук, et al.
Endokrynologia (2023) Vol. 28, Iss. 4, pp. 349-362
Open Access | Times Cited: 3
V.M. Pushkarev, О.І. Ковзун, Н.І. Левчук, et al.
Endokrynologia (2023) Vol. 28, Iss. 4, pp. 349-362
Open Access | Times Cited: 3
ScRNA-Seq study of neutrophils reveals vast heterogeneity and breadth of inflammatory responses in severe COVID-19 patients
Jintao Xu, Bing He, Kyle Carver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Jintao Xu, Bing He, Kyle Carver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Extracellular vesicles and angiotensin-converting enzyme 2 in COVID-19 disease
Yu Liu, ROBERT J. KASPER, NATALIE J. S. CHOI
Biocell (2024) Vol. 48, Iss. 1, pp. 1-8
Open Access
Yu Liu, ROBERT J. KASPER, NATALIE J. S. CHOI
Biocell (2024) Vol. 48, Iss. 1, pp. 1-8
Open Access
Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine?
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 5, pp. 318-319
Closed Access
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 5, pp. 318-319
Closed Access
